🇺🇸 FDA
Patent

US 12090126

Methods of administering solriamfetol to lactating women

granted A61KA61K31/165

Quick answer

US patent 12090126 (Methods of administering solriamfetol to lactating women) held by AXSOME MALTA LTD. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/165